Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable

BACKGROUND: No tools to predict the probability of extrahepatic disease progression (ePD) of initially unresectable, liver-limited metastatic colorectal cancer (mCRC) are currently available. To estimate the likelihood to develop ePD and to identify clinical and molecular factors that could predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Ongaro, Elena, Cremolini, Chiara, Rossini, Daniele, Corti, Francesca, Pagani, Filippo, Morelli, Luca, Urbani, Lucio, Masi, Gianluca, Sposito, Carlo, Filippi, Beatrice, Borelli, Beatrice, Zucchelli, Gemma, Moretto, Roberto, Boccaccino, Alessandra, Solaini, Leonardo, de Braud, Filippo, Mazzaferro, Vincenzo, Falcone, Alfredo, Cucchetti, Alessandro, Pietrantonio, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555604/
https://www.ncbi.nlm.nih.gov/pubmed/31231562
http://dx.doi.org/10.1136/esmoopen-2019-000496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555604/
https://www.ncbi.nlm.nih.gov/pubmed/31231562
http://dx.doi.org/10.1136/esmoopen-2019-000496

Ejemplares similares